Trusteesof the Griffin Institute

Professor Robin Kennedy, MS, FRCS

Chairman, Visiting professor of surgery, Imperial College London, Retired Consultant Colorectal Surgeon, St Mark’s Hospital, London

Robin Kennedy worked as a consultant surgeon based in Somerset and, from 2006, at St Mark’s Hospital, London, specializing in bowel surgery. His work involved developing and testing new approaches in bowel surgery, particularly using keyhole (laparoscopic) techniques and enhanced recovery programmes. He holds the post of Visiting Professor of Surgery in the Department of Surgery and Cancer, Imperial College London. In 2016 he became Chairman of The Griffin Institute. Robin retired from St Mark’s Hospital in 2017 but taught surgeons in Denmark until recently and is involved in the design of novel surgical equipment.

Mr Bruce Mauleverer, QC, FClArb, MA

Vice Chairman, Retired barrister

Bruce Mauleverer QC is a retired Barrister, Deputy High Court Judge, Arbitrator and Mediator. He is currently Patron of the International Law Association and Chairman of The Listen Charity. Since his retirement from professional practice, he has been a trustee of charities including UNICEF UK, MapAction, the Mortimer Society and The Tavistock Centre for Couple Relationships. He was also Chairman of The Jubilee Sailing Trust.

Bruce has many other interests including property law and governance issues in the voluntary sector.

Professor Vivek Mudera, PhD

Vice Dean Education Faculty of Medical Sciences and Director Division of Surgery and Interventional Science, University College London

Vivek Mudera is the Institute Director of Education at UCL Division of Surgery and Interventional Science. His main research themes include in vitro and in vivo musculoskeletal engineering and wound healing. He is the Director of Education at the Institute of Orthopaedics and Musculoskeletal Science, Graduate Tutor for the Division of Surgery and Interventional Sciences and Educational Lead on the Divisional Executive Committee. 

Vivek is also an active member of the UK Tissue Engineering Community, and an elected member of the Engineering and Physical Sciences Research Council College. Highlights of his work include the investigation of the role of specific cell migration during flexor tendon healing and formation of adhesions; the prevention of adhesion formation using protein blockers to inhibit cell migration; and the identification of cellular mechanisms in Dupuytren’s Contracture and Frozen Shoulder.

Mr Hugo Robinson, MA, FCA

Treasurer, Partner at Kings Park Capital and a Fellow of The Institute of Chartered Accountants in England and Wales

Hugo Robinson has over 25 years experience in the finance and investment industry, having qualified as a Chartered Accountant at Price Waterhouse before moving into investment banking with UBS and, most recently, co-founding Kings Park Capital. He is also a trustee and Chair of the St Giles in the Fields and Willliam Shelton Educational Charity.

Mr Simon Hubbert

Co-founder and Chief Executive Officer of RHYTHM AI Ltd, a UK-based medical technology company in the cardiac rhythm mapping space

Simon has over 25 years experience in the medical device industry and has held CEO, Senior commercial and general management position in both public and private global medtech companies, including Johnson & Johnson, Medtronic, Lombard Medical and LMA International.

Kate Forster,

Director of Operations Europe, BioLegend

Kate has over 20 years experience in human resources. Providing HR and organizational design advice to small business, mainly in healthcase related industries and tech, also charites/not for profits. Primarily in the UK and USA.

Dr Janet Allen, MD, FRSE

Director of Strategic Innovation at The Cystic Fibrosis Trust 

Janet Allen trained as a physician and practised in academic medical centres. Following post-doctoral training at Harvard Medical School, she gained faculty positions at the University of Cambridge and was then appointed Chair of Molecular Medicine at University of Glasgow. She moved to senior management posts in Parke Davis and then Pfizer.  

Since 2002, Janet has been involved in developing research strategies for the Conway Institute at University College Dublin and for the Biotechnology and Biological Sciences Research Council. She joined the Cystic Fibrosis Trust in 2012, where she is now Director of Strategic Innovation.

Professor Anthony Goldstone, CBE

Professor of Haematology, Medical Director HCA UK at University College Hospital & Chair of the HCA UK Cancer Department

Professor Anthony Goldstone is the Medical Director at HCA UK at University College Hospital and Chair of the HCA UK Cancer Department.

Professor Goldstone joined University College Hospital in 1976 as a Consultant Haematologist and played a pivotal role in setting up the leukaemia and lymphoma transplant service there. He became the hospitals first Clinical Director in 1988 and the first Medical Director in 1992. He is the former Medical Director of the North London Cancer Network, former President of the British Society for Haematology and was awarded CBE in June 2008 for Services to Medicine. He also served as President of SOHO (Society of Haematological Oncology) a major International Haematology Clinical & research society.

Since HCA’s first NHS partnership in 2006 Professor Goldstone has been instrumental in the success of our longstanding partnership with University College Hospital and continues to support the joint venture in his role as Medical Director. Professor Goldstone is Chair of the HCA UK Cancer Department and facilitates our focus on innovation, quality improvement and growth within the department.

Professor Goldstone served as Chair of RNOH NHST for 8.5 years from Feb 2011. During that period the CQC rating improved from “Requires Improvement” to “Good”. Also during that period, the new Stanmore building at RNOH (Royal National Orthopaedic Hospital) was built & opened, the first significant new build on that site for 50 years. This added over 100 beds to the facility the vast majority of them single rooms.

Mr. Bertie Leigh Hon FRCA and FRCPCH, FRCOG ad eundem

Ex Senior partner at Hempsons Solicitors with extensive experience in clinical negligence, commonly acting for doctors and NHS Resolution. He has also advised a number of medical bodies and Royal Colleges. He is the former Chairman of NCEPOD and was Non-Executive Director on the Board of the Royal National Orthopaedic Hospital Stanmore. Member of Council British Orthopaedic Association and the Gross Negligence Manslaughter Committee advising the GMC.

Bonella Ramsay

(Bio coming soon)

Gavin Jell

(Bio coming soon)